Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA unpersuaded by P&G's answer to Crest Gum Care warning letter; threatens legal action.

This article was originally published in The Tan Sheet

Executive Summary

FDA UNPERSUADED BY P&G's RESPONSE TO CREST GUM CARE WARNING LETTER, the agency told the company in a Nov. 17 letter. Responding to an Oct. 18 letter from Procter & Gamble, FDA stated that its "position regarding the status of Crest Gum Care toothpaste is unchanged." FDA said the toothpaste "is subject to the risk of further legal action as noted in the warning letter" if P&G continues to market the product.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel